List of United Biomedical, Inc. (Ubi) patents

List of United Biomedical, Inc. (Ubi) patents

List of ESPROS Photonics Corporation patents

List of Virident Systems patents

List of Arkema patents

List of companies in Analytics Ventures's investment portfolio

List of awards received by Glenn Close

Patents where

Current Assignee

Name

is

‌

United Biomedical, Inc. (Ubi)

	Name	Description	Patent Applicant	Current Assignee	Inventor	Patent Jurisdiction	Patent Number	Date of Patent
	‌ US Patent 9102752 Peptide vaccine for prevention and immunotherapy of dementia of the Alzheimer's type	Patent 9102752 was granted and assigned to United Biomedical, Inc. (Ubi) on August, 2015 by the United States Patent and Trademark Office.	‌ United Biomedical, Inc. (Ubi)	‌ United Biomedical, Inc. (Ubi)		United States Patent and Trademark Office	9102752	August 11, 2015
	‌ US Patent 7872110 Deimmunized monoclonal antibodies for protection against HIV exposure and treatment of HIV infection	Patent 7872110 was granted and assigned to United Biomedical, Inc. (Ubi) on January, 2011 by the United States Patent and Trademark Office.		‌ United Biomedical, Inc. (Ubi)		United States Patent and Trademark Office	7872110	January 18, 2011
	‌ US Patent 7648701 Peptide composition as immunogen for the treatment of allergy	Patent 7648701 was granted and assigned to United Biomedical, Inc. (Ubi) on January, 2010 by the United States Patent and Trademark Office.		‌ United Biomedical, Inc. (Ubi)		United States Patent and Trademark Office	7648701	January 19, 2010
	‌ US Patent 7951909 Immunogenic peptide composition comprising a promiscuous helper T cell epitope and an N-terminal fragment of Aβ	Patent 7951909 was granted and assigned to United Biomedical, Inc. (Ubi) on May, 2011 by the United States Patent and Trademark Office.		‌ United Biomedical, Inc. (Ubi)		United States Patent and Trademark Office	7951909	May 31, 2011
	‌ US Patent 8232373 Immunogenic peptide composition for the prevention and treatment of alzheimer's disease	Patent 8232373 was granted and assigned to United Biomedical, Inc. (Ubi) on July, 2012 by the United States Patent and Trademark Office.		‌ United Biomedical, Inc. (Ubi)		United States Patent and Trademark Office	8232373	July 31, 2012
	‌ US Patent 10420832 Synthetic peptide-based emergency vaccine against foot and mouth disease (FMD)	Patent 10420832 was granted and assigned to United Biomedical, Inc. (Ubi) on September, 2019 by the United States Patent and Trademark Office.	‌ United Biomedical, Inc. (Ubi)	‌ United Biomedical, Inc. (Ubi)		United States Patent and Trademark Office	10420832	September 24, 2019
	‌ US Patent 7501494 Designed deimmunized monoclonal antibodies for protection against HIV exposure and treatment of HIV infection	Patent 7501494 was granted and assigned to United Biomedical, Inc. (Ubi) on March, 2009 by the United States Patent and Trademark Office.		‌ United Biomedical, Inc. (Ubi)		United States Patent and Trademark Office	7501494	March 10, 2009
	‌ US Patent 8084015 Stabilized synthetic immunogen delivery system	Patent 8084015 was granted and assigned to United Biomedical, Inc. (Ubi) on December, 2011 by the United States Patent and Trademark Office.		‌ United Biomedical, Inc. (Ubi)		United States Patent and Trademark Office	8084015	December 27, 2011
	‌ US Patent 10300123 Synthetic peptide-based marker vaccine and diagnostic system for effective control of porcine reproductive and respiratory syndrome (PRRS)	Patent 10300123 was granted and assigned to United Biomedical, Inc. (Ubi) on May, 2019 by the United States Patent and Trademark Office.		‌ United Biomedical, Inc. (Ubi)		United States Patent and Trademark Office	10300123	May 28, 2019
	‌ US Patent 9932372 Designer peptide-based PCV2 vaccine	Patent 9932372 was granted and assigned to United Biomedical, Inc. (Ubi) on April, 2018 by the United States Patent and Trademark Office.		‌ United Biomedical, Inc. (Ubi)		United States Patent and Trademark Office	9932372	April 3, 2018
	‌ US Patent 6906169 Immunogenic peptide composition comprising measles virus Fprotein Thelper cell epitope (MUFThl-16) and N-terminus of β-amyloid peptide	Patent 6906169 was granted and assigned to United Biomedical, Inc. (Ubi) on June, 2005 by the United States Patent and Trademark Office.		‌ United Biomedical, Inc. (Ubi)		United States Patent and Trademark Office	6906169	June 14, 2005

11 results

0 selected

11 results

0 selected